Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Novartis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novartis' 2013 sales performance.

Novartis

After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream

After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream Collaborating with pharma companies, Oxford Biomedica uses its infrastructure to produce other companies’ licensed products, including Novartis’ Kymriah treatment (alongside other undisclosed CAR-T-related products).

Chaperone Leadership

Chaperone Leadership While I’m prepared to accept a few shared basics, the idea that leading Novartis is the same as leading McDonalds seems preposterous.

GSK pays $85m upfront for Surface Oncology’s lead cancer drug

GSK pays $85m upfront for Surface Oncology’s lead cancer drug The biotech also has a clinical-stage collaboration programme with Novartis which includes a CD73-targeting asset – NZV930. ... Novartis signed an agreement with Surface in  2016 to license four preclinical programmes from Surface’s portfolio.

Novartis receives FDA breakthrough therapy designation for rare disease med

Novartis receives FDA breakthrough therapy designation for rare disease med Iptacopan is the most advanced asset in our nephrology pipeline.” said John Tsai, head of global drug development and chief medical officer at Novartis. ... Alexion’s other long-acting C5 inhibitor, Ultomiris (ravulizumab‑cwvz) is also approved in

Novartis eyes 2021 regulatory submissions for ‘STAMP’ inhibitor asciminib

Novartis eyes 2021 regulatory submissions for ‘STAMP’ inhibitor asciminib Investigational drug beat Pfizer's Bosulif in phase 3 study. Novartis’ investigational treatment asciminib induced a superior molecular response rate (MMR) compared to Pfizer’s Bosulif in chronic myeloid leukaemia patients ... Novartis has been at

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes....

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...